Nexentis Technologies Inc. (NXTS)
NASDAQ: NXTS · Real-Time Price · USD
0.910
-0.030 (-3.16%)
At close: Mar 6, 2026, 4:00 PM EST
0.875
-0.035 (-3.86%)
After-hours: Mar 6, 2026, 7:23 PM EST
Nexentis Technologies Employees
As of December 31, 2024, Nexentis Technologies had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees increased by 2 or 66.67% compared to the previous year.
Employees
5
Change (1Y)
2
Growth (1Y)
66.67%
Revenue / Employee
$41,800
Profits / Employee
-$1,329,200
Market Cap
2.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| The Beauty Health Company | 769 |
| Acme United | 633 |
| Grove Collaborative Holdings | 415 |
| European Wax Center | 203 |
| Solesence | 98 |
| Tantech Holdings | 69 |
| Big Tree Cloud Holdings | 50 |
| Pitanium | 48 |
NXTS News
- 16 days ago - N2OFF, Inc. Provides Early Warning Disclosure - TheNewswire
- 4 weeks ago - In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions - GlobeNewsWire
- 6 weeks ago - N2OFF: MitoCareX Bio Announces Positive In Vitro Results from Its Mitochondrial Carrier Small Molecule Platform - GlobeNewsWire
- 7 weeks ago - N2OFF: MitoCareX Bio Spotlights Co-Founder's Pioneering Research on Mitochondrial Carriers in Spaceflight Stress Conditions - GlobeNewsWire
- 2 months ago - N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake - GlobeNewsWire
- 2 months ago - N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy - GlobeNewsWire
- 3 months ago - N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination - GlobeNewsWire
- 4 months ago - N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers - GlobeNewsWire